The Covid-19 vaccine being established at the University of Oxford is safe and causes an immune response, findings of the very first stages of the research study recommend.
The findings on the Oxford vaccine trial were released in medical journal, The Lancet.
Professor Sarah Gilbert, of the University of Oxford, stated: ‘There is still much work to be done prior to we can validate if our vaccine will assist handle the Covid-19 pandemic, however these early outcomes hold guarantee.
‘As well as continuing to evaluate our vaccine in phase-three trials, we require to get more information about the infection – for instance, we still do not understand how strong an immune reaction we require to provoke to efficiently secure versus Sars-Cov-2 infection.
“If our vaccine works, it is an appealing choice as these kinds of vaccine can be produced at big scale.
Visit our live blog site for the current updates: Coronavirus news live
‘A successful vaccine against Sars-Cov-2 could be used to prevent infection, disease and death in the whole population, with high-risk populations such as hospital workers and older adults prioritised to receive vaccination.’
Health Secretary Matt Hancock stated the upgrade on the vaccine was ‘very encouraging news’.
He tweeted: ‘We have actually currently purchased 100 million dosages of this vaccine, must it prosper.
‘Congratulations to the scientists at @UniofOxford & @OxfordVacGroup and leadership of @AstraZeneca.’
Boris Johnson tweeted: ‘This is extremely favorable news. A substantial well done to our dazzling, world-leading researchers & scientists at @UniofOxford.
‘There are no guarantees, we’re not there yet & even more trials will be essential – however this is an essential action in the ideal instructions.’
Get in touch with our news group by emailing us at webnews@metro.co.uk.
For more stories like this, inspect our news page.
Get the need-to-know coronavirus news, functions and ideas, right to your inbox.